Cargando…

CD1d expression in glioblastoma is a promising target for NKT cell-based cancer immunotherapy

Glioblastoma is the most common and aggressive type of brain tumor with high recurrence and fatality rates. Although various therapeutic strategies have been explored, there is currently no effective treatment for glioblastoma. Recently, the number of immunotherapeutic strategies has been tested for...

Descripción completa

Detalles Bibliográficos
Autores principales:	Hara, Ayaka, Koyama-Nasu, Ryo, Takami, Mariko, Toyoda, Takahide, Aoki, Takahiro, Ihara, Fumie, Kobayashi, Masayoshi, Hirono, Seiichiro, Matsutani, Tomoo, Nakayama, Toshinori, Iwadate, Yasuo, Motohashi, Shinichiro
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Springer Berlin Heidelberg 2020
Materias:	Original Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8053161/ https://www.ncbi.nlm.nih.gov/pubmed/33128583 http://dx.doi.org/10.1007/s00262-020-02742-1

Ejemplares similares

Clinical Application of iNKT Cell-mediated Anti-tumor Activity Against Lung Cancer and Head and Neck Cancer
por: Takami, Mariko, et al.
Publicado: (2018)

STMO-3 Mid- to long-term outcome of supratotal resection of IDH1 wild-type glioblastoma based on 11C-methionine PET: a retrospective, single-center study
por: Hirono, Seiichiro, et al.
Publicado: (2021)

Oncological and functional outcomes of supratotal resection of IDH1 wild-type glioblastoma based on (11)C-methionine PET: a retrospective, single-center study
por: Hirono, Seiichiro, et al.
Publicado: (2021)

NQPC-05 BEVACIZUMAB AFTER PROGRESSION OF GLIOBLASTOMA PROLONGS PATIENT’S LIVING TIME AT HOME IN THE LAST 90 DAYS
por: Matsutani, Tomoo, et al.
Publicado: (2019)

STMO-05 SURGICAL AND FUNCTIONAL OUTCOME OF AWAKE SURGERY FOR INSULAR GLIOMA
por: Hirono, Seiichiro, et al.
Publicado: (2019)

Real-time methylation-specific PCR for the evaluation of methylation status of MGMT gene in glioblastoma
por: Yoshioka, Masaki, et al.
Publicado: (2018)

STMO-13 PATHOLOGICAL EVALUATION AND ONCOLOGICAL OUTCOME OF FLAIRECTOMY IN PATIENTS WITH IDH1 WILD-TYPE GLIOBLASTOMA
por: Hirono, Seiichiro, et al.
Publicado: (2022)

STMO-11 Supratotal resection of Glioblastoma with Methionine PET
por: Ko, Ozaki, et al.
Publicado: (2020)

Activated invariant natural killer T cells directly recognize leukemia cells in a CD1d‐independent manner
por: Aoki, Takahiro, et al.
Publicado: (2020)

Invariant NKT cells are resistant to circulating CD15(+) myeloid‐derived suppressor cells in patients with head and neck cancer
por: Horinaka, Atsushi, et al.
Publicado: (2016)

Activated iNKT cells enhance the anti-tumor effect of antigen specific CD8 T cells on mesothelin-expressing salivary gland cancer
por: Makita, Yuji, et al.
Publicado: (2018)

Phase II study of α-galactosylceramide-pulsed antigen-presenting cells in patients with advanced or recurrent non-small cell lung cancer
por: Toyoda, Takahide, et al.
Publicado: (2020)

GCT-09. HEALTH AND SOCIAL ISSUES IN THE LONG-TERM GERM-CELL TUMOR SURVIVORS
por: Matsutani, Tomoo, et al.
Publicado: (2020)

PATH-03. HIGH-GRADE NEUROEPITHELIAL TUMOR SHOWING BCOR IMMUNOPOSITIVITY WITHOUT EXON 15 INTERNAL TANDEM DUPLICATIONS IN A FIVE-YEAR-OLD BOY: A CASE REPORT
por: Wakita, Shogo, et al.
Publicado: (2020)

NKT Cells as an Ideal Anti-Tumor Immunotherapeutic
por: Fujii, Shin-ichiro, et al.
Publicado: (2013)

CS-1 Cerebellar liponeurocytoma; Report of two cases with detailed metabolic, immunohistochemical, and genetic evaluations
por: Shimizu, Miyuki, et al.
Publicado: (2021)

Immunological features of a lung cancer patient achieving an objective response with anti‐programmed death‐1 blockade therapy
por: Kamata, Toshiko, et al.
Publicado: (2019)

Regeneration of invariant natural killer T (iNKT) cells: application of iPSC technology for iNKT cell-targeted tumor immunotherapy
por: Aoki, Takahiro, et al.
Publicado: (2023)

Clinicopathological and Genomic Features of Pediatric Intracranial Myxoid Mesenchymal Tumor with both of EWSR1-CREM Gene Fusion and MAP3K13 Mutation: A Case Report and Comparison with Adult Cases in the Literature
por: SASAKI, Minami, et al.
Publicado: (2022)

Blockade of programmed death-1/programmed death ligand pathway enhances the antitumor immunity of human invariant natural killer T cells
por: Kamata, Toshiko, et al.
Publicado: (2016)

MPC-8 Serum anti-zinc finger FYVE domain-containing protein 21 (ZFYVE21) autoantibody as a novel biomarker for oligodendroglioma IDH-mutant and 1p/19q co-deletion
por: Matsutani, Tomoo, et al.
Publicado: (2021)

Soluble factors derived from neuroblastoma cell lines suppress dendritic cell differentiation and activation
por: Harada, Kazuaki, et al.
Publicado: (2019)

Molecular imaging of 1p/19q deletion in oligodendroglial tumours with (11)C-methionine positron emission tomography
por: Iwadate, Yasuo, et al.
Publicado: (2016)

Expansion of Lung Vα14 NKT Cells by Administration of α‐Galactosylceramide‐pulsed Dendritic Cells
por: Akutsu, Yasunori, et al.
Publicado: (2002)

GCT-45. YOLK SAC TUMOR IN THE CEREBELLAR VERMIS - A CASE REPORT
por: Otake, Saori, et al.
Publicado: (2020)

CD69 prevents PLZF(hi) innate precursors from prematurely exiting the thymus and aborting NKT2 cell differentiation
por: Kimura, Motoko Y., et al.
Publicado: (2018)

White matter dissection and structural connectivity of the human vertical occipital fasciculus to link vision-associated brain cortex
por: Jitsuishi, Tatsuya, et al.
Publicado: (2020)

Autologous antibody to src-homology 3-domain GRB2-like 1 specifically increases in the sera of patients with low-grade gliomas
por: Matsutani, Tomoo, et al.
Publicado: (2012)

Serum anti-SERPINE1 antibody as a potential biomarker of acute cerebral infarction
por: Kubota, Masaaki, et al.
Publicado: (2021)

Role of Evaluating MGMT Status and 1p36 Deletion in Radiosurgery-Induced Anaplastic Ependymoma That Rapidly and Completely Resolved by Temozolomide Alone: Case Report and Review of the Literature
por: Hirono, Seiichiro, et al.
Publicado: (2015)

Circulating anti-filamin C autoantibody as a potential serum biomarker for low-grade gliomas
por: Adachi-Hayama, Masayo, et al.
Publicado: (2014)

Essential Role for CD30-Transglutaminase 2 Axis in Memory Th1 and Th17 Cell Generation
por: Suzuki, Akane S., et al.
Publicado: (2020)

Antibody‐dependent cellular cytotoxicity toward neuroblastoma enhanced by activated invariant natural killer T cells
por: Mise, Naoko, et al.
Publicado: (2016)

Immunosuppressive property of submandibular lymph nodes in patients with head and neck tumors: differential distribution of regulatory T cells
por: Sakurai, Daiju, et al.
Publicado: (2018)

Association between serum anti-ASXL2 antibody levels and acute ischemic stroke, acute myocardial infarction, diabetes mellitus, chronic kidney disease and digestive organ cancer, and their possible association with atherosclerosis and hypertension
por: Li, Shu-Yang, et al.
Publicado: (2020)

Serum anti‑TSTD2 antibody as a biomarker for atherosclerosis‑induced ischemic stroke and chronic kidney disease
por: Kubota, Masaaki, et al.
Publicado: (2022)

NKT10 cells: a novel iNKT cell subset
por: Wingender, Gerhard, et al.
Publicado: (2015)

Bmi1 regulates memory CD4 T cell survival via repression of the Noxa gene
por: Yamashita, Masakatsu, et al.
Publicado: (2008)

Augmentation of Vα14 Nkt Cell–Mediated Cytotoxicity by Interleukin 4 in an Autocrine Mechanism Resulting in the Development of Concanavalin a–Induced Hepatitis
por: Kaneko, Yoshikatsu, et al.
Publicado: (2000)

NKT Cells in Sepsis
por: Leung, Briana, et al.
Publicado: (2010)

Cannot write session to /tmp/vufind_sessions/sess_88b77ndh78c5l3vpggsdr7fvjl